Metabolism and disposition of oseltamivir (OS) in rats, determined by immunohistochemistry with monospecific antibody for OS or its active metabolite oseltamivir carboxylate (OC): A possibility of transporters dividing the drugs' excretion into the bile and kidney
Abstract Among any drugs, no comparative pharmacological study on how prodrug and its active metabolite behave in animal bodies is available. Immunohistochemistry (IHCs) using newly prepared two monoclonal antibodies, AOS‐96 and AOC‐160, monospecific for oseltamivir (OS) and its metabolite oseltamiv...
Saved in:
Main Authors: | Kunio Fujiwara (Author), Yutaro Yamamoto (Author), Tetsuya Saita (Author), Senya Matsufuji (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Simultaneous quantification of prodrug oseltamivir and its metabolite oseltamivir carboxylate in human plasma by LCâMS/MS to support a bioequivalence study
by: Ajay Gupta, et al.
Published: (2013) -
Effects of dexamethasone coadministered with oseltamivir on the pharmacokinetics of oseltamivir in healthy volunteers
by: Jang K, et al.
Published: (2017) -
A physiologically-based pharmacokinetic model of oseltamivir phosphate and its carboxylate metabolite for rats and humans
by: Guanghua Gao, et al.
Published: (2019) -
Oseltamivir Enhances Hippocampal Network Synchronization
by: Atsushi Usami, et al.
Published: (2008) -
OSELTAMIVIR MEDICATION IN THE PEDIATRIC PRACTICE: THE REVIEW
by: A.B. Ivanyuk, et al.
Published: (2008)